What Is Lytenava, and How Does It Work? Lytenava (bevacizumab) is now FDA approved to treat adults with neovascular age-related macular degeneration, which is also called wet AMD. Wet AMD is an eye ...
Age-related macular degeneration (AMD) is an eye condition that can affect central vision, which is the vision used for activities such as reading and recognizing faces. In people with wet AMD, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results